NCT06479772View on ClinicalTrials.gov

Evaluation of the Potential Impact of an Artificial Intelligence Solution in Second Reading of Organized Screening.

CompletedOBSERVATIONAL

Enrollment

55,589

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions

Breast Cancer Female

Trial Locations (1)

69008

Hôpital Privé Jean Mermoz, Lyon

All Listed Sponsors

collaborator

Vivactis M2Research

INDUSTRY

lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER